octanoic acid is a lipid of Fatty Acyls (FA) class. Octanoic acid is associated with abnormalities such as Ischemia, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes, Cardiomyopathies and Obesity. The involved functions are known as Anabolism, 5-(carboxyamino)imidazole ribonucleotide mutase activity, Citric Acid Cycle, Metabolic Inhibition and Excretory function. Octanoic acid often locates in Pore, Protoplasm, Endothelium, Mitochondria and Muscle. The associated genes with octanoic acid are P4HTM gene, CPT1A gene, HADH gene, ACSL1 Gene and CD36 gene. The related lipids are Fatty Acids, Nonesterified Fatty Acids, Oleates, Palmitates and hexanoic acid.
To understand associated biological information of octanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
octanoic acid is suspected in Obesity, Atherosclerosis, Gigantism, Alzheimer's Disease, Neurodegenerative Disorders, Cardiomyopathies and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with octanoic acid
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Satou M et al. | Understanding the functional significance of ghrelin processing and degradation. | 2011 | Peptides | pmid:21763742 |
Rucinski M et al. | Evidence suggesting that ghrelin O-acyl transferase inhibitor acts at the hypothalamus to inhibit hypothalamo-pituitary-adrenocortical axis function in the rat. | 2012 | Peptides | pmid:22543218 |
Wang J et al. | Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers. | 2006 | Peptides | pmid:16242213 |
Sulkers EJ et al. | Quantitation of oxidation of medium-chain triglycerides in preterm infants. | 1989 | Pediatr. Res. | pmid:2797943 |
Jones PM et al. | Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency. | 2003 | Pediatr. Res. | pmid:12621125 |
Trauner DA and Adams H | Intracranial pressure elevations during octanoate infusion in rabbits: an experimental model of Reye's syndrome. | 1981 | Pediatr. Res. | pmid:7267183 |
Nakajima T et al. | The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. | 1997 | Pediatr. Res. | pmid:9212045 |
Whyte RK et al. | Excretion of dicarboxylic and omega-1 hydroxy fatty acids by low birth weight infants fed with medium-chain triglycerides. | 1986 | Pediatr. Res. | pmid:3080726 |
Trauner DA | Regional cerebral Na+K+ ATPase activity following octanoate administration. | 1980 | Pediatr. Res. | pmid:6250122 |
Yoshida Y et al. | Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism. | 1988 | Pediatr. Res. | pmid:3353181 |
Roe CR et al. | Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency. | 1985 | Pediatr. Res. | pmid:4000772 |
Dombrowski GJ and Swiatek KR | Lactate genesis by rat liver and muscle during development. | 1991 | Pediatr. Res. | pmid:1956716 |
Trauner DA and Garrett RS | Effect of octanoate injection on rat blood-brain barrier. | 1985 Jan-Feb | Pediatr. Neurol. | pmid:3880386 |
Trauner DA and de la Torre JC | Effect of octanoate on blood-brain barrier permeability using L-dopa as a marker. | 1985 Jul-Aug | Pediatr. Neurol. | pmid:3880408 |
Trice JE and Trauner DA | Alterations in serum glucose and hepatic glycogen concentrations during octanoate administration in rabbits. | 1985 Sep-Oct | Pediatr. Neurol. | pmid:3880415 |
Trauner DA and Adams HR | Effects of therapeutic agents in a rabbit model of Reye syndrome. | 1987 May-Jun | Pediatr. Neurol. | pmid:3508061 |
Massaldi H and Morais V | Evolution of endotoxin contamination during production of a therapeutic serum. | 2007 Sep-Oct | PDA J Pharm Sci Technol | pmid:18047176 |
Tezikov EB et al. | [Effect of beta-hydroxybutyrate and caprylic acid on function of isolated rat heart in alcoholic intoxication and in the post-intoxication period]. | 1993 May-Jun | Patol Fiziol Eksp Ter | pmid:8058394 |
Müller T | Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference. | 2009 | Patient Prefer Adherence | pmid:19936145 |
Webb T | Identification of interference affecting the gas-liquid chromatography analysis of valproic acid in quality control material. | 1986 | Pathology | pmid:3097616 |